These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.
    Author: Singer FR, Fredericks RS, Minkin C.
    Journal: Arthritis Rheum; 1980 Oct; 23(10):1148-54. PubMed ID: 7000081.
    Abstract:
    During the initial months of long-term treatment of Paget's disease of bone with salmon calcitonin, circulating alkaline phosphatase activity and urinary hydroxyproproline excretion usually decrease by about 50%. In 22 of 85 patients these parameters returned to pretreatment levels despite continuous therapy. Nineteen patients who were resistant to salmon calcitonin had salmon calcitonin antibodies in high titer. Human calcitonin has been effective in suppressing disease activity in these patients. The pathogenesis of calcitonin resistance in patients without antibodies is unknown.
    [Abstract] [Full Text] [Related] [New Search]